Publikationen

Veröffentlichungsjahr: 2022
Assessment of genetically modified maize MON 95379 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2020-170) by Bayer TESTBIOTECH Background 15 - 12 - 2022 2022 Testbiotech_Comment_ mon_95379_fin.pdf
Assessment of genetically modified Maize MON 87429 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-161) by Bayer TESTBIOTECH Background 18 - 12 - 2022 2022 Testbiotech_Comment_ MON_87429.pdf
Unintended effects caused by techniques of new genetic engineering create a new quality of hazards and risks 2022 New_GE_unintended_effects_2.pdf
Cultivation of Bt cowpea may impact health and the environment 2022 Bt_Cowpea_risk assessment.pdf
Testbiotech comment on EFSA’s assessment of genetically engineered maize NK603 x T25 x DAS-40278-9 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-164) from Pioneer TESTBIOTECH Background 17 - 01 - 2022 2022 Testbiotech_Comment_NK603xT25xDAS40278-9_v2.pdf
Assessment of genetically modified maize MON 89034 × 1507 × MIR162 × NK603 × DAS-40278-9 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2018-151) by Dow AgroSciences TESTBIOTECH Background 12 - 9 - 2022 2022 Testbiotech_Comment_MON 89034 x 1507 x MIR162 x NK603 x DAS40278-9_fin.pdf
New Genomic Techniques and unintended genetic changes: EFSA ‘overlooked’ most of the relevant publications TESTBIOTECH Background 12 - 12 - 2022 2022 EFSA ‘overlooked’ relevant publications.pdf
Testbiotech letter to the European Commission and Technopolis Group on the targeted stakeholder consultation on NGTs 2022 Letter Testbiotech_Technopolis.pdf
Twisted facts and incorrect assumptions about NGT plants - Misleading report published by STOA TESTBIOTECH Background 13-10-2022 2022 Testbiotech comment on report from STOA.pdf
Testbiotech comment on EFSA’s assessment of genetically engineered oilseed rape MON 94100 (application EFSA-GMO-NL-2020-169) from Bayer TESTBIOTECH Background 25 - 08 - 2022 2022 Testbiotech_Comment_94100.pdf

Seiten